Home  |  Archive  |  Online Submission  |  News & Events  |  Subscribe  |  APFA  |  Society  |  Links  |  Contact Us  |  中文版
Search   
 
Journal

Ahead of print
Authors' Accepted
    Manuscripts
new!
Current Issue
Archive
Acknowledgments
Special Issues
Browse by Category

Manuscript Submission

Online Submission
Online Review
Instruction for Authors
Instruction for Reviewers
English Corner new!

About AJA

About AJA
Editorial Board
Contact Us
News

Resources & Services

Advertisement
Subscription
Email alert
Proceedings
Reprints

Download area

Copyright licence
EndNote style file
Manuscript word template
Guidance for AJA figures
    preparation (in English)

Guidance for AJA figures
    preparation (in Chinese)

Proof-reading for the
    authors

AJA Club (in English)
AJA Club (in Chinese)

Links

Meetings
Journals
Societies & Institutes
Hospitals
Databases & Libraries
Companies
Websites
Other links

 
Prostate Disease

Volume 21, Issue 1 (Jan 2019)
The 14th international prostate forum
Mevlana Derya Balbay, Abdullah Erdem Canda
Asian J Androl 21: 1-2; 10.4103/aja.aja_108_18
Full TextPDF PDF

PSA screening - for whom and when?
Peter Albers
Asian J Androl 21: 3-5; 10.4103/aja.aja_37_17
Abstract |Full TextPDF PDF

Current and emerging trends in prostate cancer immunotherapy
Adam Schatz, Badar M Mian
Asian J Androl 21: 6-11; 10.4103/aja.aja_52_17
Abstract |Full TextPDF PDF

Current concepts and trends in the treatment of bone metastases in patients with advanced prostate cancer
Miriam Hegemann, Moritz Maas, Steffen Rausch, Simon Walz, Jens Bedke, Arnulf Stenzl, Tilman Todenhöfer
Asian J Androl 21: 12-18; 10.4103/aja.aja_59_17
Abstract |Full TextPDF PDF

Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians
Silvia Gasparrini1, Alessia Cimadamore1, Marina Scarpelli1, Francesco Massari2, Andrea Doria1, Roberta Mazzucchelli1, Liang Cheng3, Antonio Lopez-Beltran4, Rodolfo Montironi1
Asian J Androl 21: 19-23; DOI:10.4103/aja.aja_24_17
Abstract |Full TextPDF PDF

Circulating tumor cells and their role in prostate cancer
Moritz Maas, Miriam Hegemann, Steffen Rausch, Jens Bedke, Arnulf Stenzl, Tilman Todenhöfer
Asian J Androl 21: 24-31; 10.4103/aja.aja_29_17
Abstract |Full TextPDF PDF

Radical prostatectomy in patients aged 75 years or older: review of the literature
Philipp Mandel1, Thenappan Chandrasekar2, Felix K Chun3, Hartwig Huland1, Derya Tilki1,3
Asian J Androl 21: 32-36; 10.4103/aja.aja_43_17
Abstract |Full TextPDF PDF

Focal therapy for localized prostate cancer: is there a “middle ground” between active surveillance and definitive treatment?
Cihan H Demirel, Muammer Altok, John W Davis
Asian J Androl 21: 37-44; 10.4103/aja.aja_64_18
Abstract |Full TextPDF PDF

Pretreatment serum albumin/globulin ratio as a prognostic biomarker in metastatic prostate cancer patients treated with maximal androgen blockade
Ning Wang1,2, Jian-Ye Liu1,2, Xiong Li2,3,4, Min-Hua Deng1,2, Zhi Long1,2, Jin Tang1,2, Kun Yao1,2, Yi-Chuan Zhang1,2, Le-Ye He1,2
Asian J Androl 21: 56-61; 10.4103/aja.aja_50_18
Abstract |Full TextPDF PDF

Lycopene exerts anti-inflammatory effect to inhibit prostate cancer progression
Li-Ning Jiang1,2, Ya-Bin Liu1, Bing-Hui Li1
Asian J Androl 21: 80-85; 10.4103/aja.aja_70_18
Abstract |Full TextPDF PDF

[首页] [前一页][后一页] [尾页]  共有50页,10条记录

 
Copyright 1999-2017  Shanghai Materia Medica, Shanghai Jiao Tong University.  All rights reserved